119 related articles for article (PubMed ID: 26603719)
21. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
Pastores GM; Barnett NL; Kolodny EH
Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
[TBL] [Abstract][Full Text] [Related]
22. In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase.
Bondar C; Mucci J; Crivaro A; Ormazabal M; Ceci R; Oliveri B; González D; Rozenfeld P
Bone; 2017 Oct; 103():262-269. PubMed ID: 28736246
[TBL] [Abstract][Full Text] [Related]
23. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
Rosenbloom B; Balwani M; Bronstein JM; Kolodny E; Sathe S; Gwosdow AR; Taylor JS; Cole JA; Zimran A; Weinreb NJ
Blood Cells Mol Dis; 2011 Jan; 46(1):95-102. PubMed ID: 21067946
[TBL] [Abstract][Full Text] [Related]
24. Whole body MRI in type I Gaucher patients: evaluation of skeletal involvement.
Poll LW; Cox ML; Godehardt E; Steinhof V; vom Dahl S
Blood Cells Mol Dis; 2011 Jan; 46(1):53-9. PubMed ID: 21056931
[TBL] [Abstract][Full Text] [Related]
25. Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction.
Elstein D; Foldes AJ; Zahrieh D; Cohn GM; Djordjevic M; Brutaru C; Zimran A
Blood Cells Mol Dis; 2011 Jun; 47(1):56-61. PubMed ID: 21536468
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.
Boomsma JM; van Dussen L; Wiersma MG; Groener JE; Aerts JM; Maas M; Hollak CE
Blood Cells Mol Dis; 2010 Mar; 44(3):181-7. PubMed ID: 20074983
[TBL] [Abstract][Full Text] [Related]
27. Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
Biegstraaten M; Cox TM; Belmatoug N; Berger MG; Collin-Histed T; Vom Dahl S; Di Rocco M; Fraga C; Giona F; Giraldo P; Hasanhodzic M; Hughes DA; Iversen PO; Kiewiet AI; Lukina E; Machaczka M; Marinakis T; Mengel E; Pastores GM; Plöckinger U; Rosenbaum H; Serratrice C; Symeonidis A; Szer J; Timmerman J; Tylki-Szymańska A; Weisz Hubshman M; Zafeiriou DI; Zimran A; Hollak CEM
Blood Cells Mol Dis; 2018 Feb; 68():203-208. PubMed ID: 28274788
[TBL] [Abstract][Full Text] [Related]
28. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
29. High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease.
Taddei TH; Dziura J; Chen S; Yang R; Hyogo H; Sullards C; Cohen DE; Pastores G; Mistry PK
J Inherit Metab Dis; 2010 Jun; 33(3):291-300. PubMed ID: 20354791
[TBL] [Abstract][Full Text] [Related]
30. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
[TBL] [Abstract][Full Text] [Related]
31. Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.
Dinur T; Istaiti M; Frydman D; Becker-Cohen M; Szer J; Zimran A; Revel-Vilk S
Orphanet J Rare Dis; 2020 Oct; 15(1):284. PubMed ID: 33050940
[TBL] [Abstract][Full Text] [Related]
32. [Bone manifestations of Gaucher's disease in Mexican patients].
Blass PJ
Acta Ortop Mex; 2010; 24(5):351-8. PubMed ID: 21246808
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan.
Narita A; Koto Y; Noto S; Okada M; Ono M; Baba T; Sagara R; Sakai N
Orphanet J Rare Dis; 2024 Jan; 19(1):11. PubMed ID: 38183145
[TBL] [Abstract][Full Text] [Related]
34. Osteopontin: a potential biomarker of Gaucher disease.
Vairo F; Sperb-Ludwig F; Wilke M; Michellin-Tirelli K; Netto C; Neto EC; Schwartz I
Ann Hematol; 2015 Jul; 94(7):1119-25. PubMed ID: 25875742
[TBL] [Abstract][Full Text] [Related]
35. Bone marker alterations in patients with type 1 Gaucher disease.
Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of bone involvement in patients with Gaucher disease: a semi-quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi-quantitative methods used so far.
Komninaka V; Kolomodi D; Christoulas D; Marinakis T; Papatheodorou A; Repa K; Voskaridou E; Revenas K; Terpos E
Eur J Haematol; 2015 Oct; 95(4):342-51. PubMed ID: 25645321
[TBL] [Abstract][Full Text] [Related]
38. [Gaucher disease diagnosed in pediatrics: an early bone involvement].
Kennouche S; Bakir R
Presse Med; 2009 Dec; 38 Suppl 2():2S50-2. PubMed ID: 20304307
[No Abstract] [Full Text] [Related]
39. Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients.
Machaczka M; Paucar M; Björkvall CK; Smith NJC; Cox TM; Forsgren L; Svenningsson P
Blood Cells Mol Dis; 2018 Feb; 68():86-92. PubMed ID: 27789132
[TBL] [Abstract][Full Text] [Related]
40. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
Maas M; Hollak CE; Akkerman EM; Aerts JM; Stoker J; Den Heeten GJ
AJR Am J Roentgenol; 2002 Oct; 179(4):961-5. PubMed ID: 12239046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
